Reducing the incidence of predictors of cardio-metabolic disease and dysglycaemia with lifestyle modification in at-risk persons – results of further analyses of DIABRISK-SL in those below 18 years of age

BACKGROUND: We have previously demonstrated in the DIABRISK-SL trial that a trimonthly pragmatic lifestyle modification (P-LSM), as compared to a 12-monthly LSM advice (C-LSM), significantly reduced the primary composite endpoint of predictors of cardio-metabolic disease (new onset type 2 diabetes (...

Descripción completa

Detalles Bibliográficos
Autores principales: Fountoulakis, Nikolaos, Wijesuriya, Mahen, Gnudi, Luigi, Gulliford, Martin, Karalliedde, Janaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751787/
https://www.ncbi.nlm.nih.gov/pubmed/31533827
http://dx.doi.org/10.1186/s12916-019-1398-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751787/
https://www.ncbi.nlm.nih.gov/pubmed/31533827
http://dx.doi.org/10.1186/s12916-019-1398-2

Ejemplares similares